Salud financiera de hoja de balance de ResMed
Salud financiera controles de criterios 6/6
ResMed tiene un patrimonio de accionistas total de $5.2B y una deuda total de $677.5M, lo que sitúa su ratio deuda-patrimonio en 13%. Sus activos y pasivos totales son $7.2B y $2.0B respectivamente. El BAIT de ResMed es de $1.5B, por lo que su ratio de cobertura de intereses es de 41. Tiene efectivo e inversiones a corto plazo que ascienden a $442.6M.
Información clave
13.0%
Ratio deuda-patrimonio
US$677.47m
Deuda
| Ratio de cobertura de intereses | 41x |
| Efectivo | US$442.58m |
| Patrimonio | US$5.20b |
| Total pasivo | US$2.03b |
| Activos totales | US$7.22b |
Actualizaciones recientes sobre salud financiera
We Think ResMed (NYSE:RMD) Can Manage Its Debt With Ease
Nov 01
Does ResMed (NYSE:RMD) Have A Healthy Balance Sheet?
Jul 29ResMed (NYSE:RMD) Seems To Use Debt Quite Sensibly
Apr 30We Think ResMed (NYSE:RMD) Can Stay On Top Of Its Debt
May 26Recent updates
Shareholders May Not Be So Generous With ResMed Inc.'s (NYSE:RMD) CEO Compensation And Here's Why
Nov 13We Think ResMed (NYSE:RMD) Can Manage Its Debt With Ease
Nov 01Here's Why We Think ResMed (NYSE:RMD) Might Deserve Your Attention Today
Oct 20ResMed Inc.'s (NYSE:RMD) Intrinsic Value Is Potentially 47% Above Its Share Price
Oct 08Why ResMed's Rally Is Just Getting Started
Sep 18ResMed Inc.'s (NYSE:RMD) Earnings Haven't Escaped The Attention Of Investors
Sep 13ResMed (NYSE:RMD) Is Increasing Its Dividend To $0.53
Aug 05Does ResMed (NYSE:RMD) Have A Healthy Balance Sheet?
Jul 29Returns On Capital Are A Standout For ResMed (NYSE:RMD)
Jul 15ResMed: Asymmetrical Value Opportunity With High Prospect Of Re-Rating
Jul 03An Intrinsic Calculation For ResMed Inc. (NYSE:RMD) Suggests It's 33% Undervalued
Jul 02ResMed (NYSE:RMD) Seems To Use Debt Quite Sensibly
Apr 30Earnings Beat: ResMed Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 30ResMed Inc.'s (NYSE:RMD) Popularity With Investors Is Clear
Apr 18With EPS Growth And More, ResMed (NYSE:RMD) Makes An Interesting Case
Mar 22Capital Investments At ResMed (NYSE:RMD) Point To A Promising Future
Mar 10An Intrinsic Calculation For ResMed Inc. (NYSE:RMD) Suggests It's 30% Undervalued
Feb 12Why ResMed Is One Of My Top Picks In 2024
Jan 22A First Look At ResMed
Jan 09ResMed Inc.'s (NYSE:RMD) Share Price Could Signal Some Risk
Dec 20Why You Should Care About ResMed's (NYSE:RMD) Strong Returns On Capital
Dec 06Shareholders May Find It Hard To Justify Increasing ResMed Inc.'s (NYSE:RMD) CEO Compensation For Now
Nov 10Are Investors Undervaluing ResMed Inc. (NYSE:RMD) By 41%?
Nov 01ResMed: Weight-Loss Drug Worries Provide Buying Opportunity
Oct 28ResMed: Stock Re-Rating To 20x Forward P/E Is A Buy Opportunity
Sep 12ResMed Has Become A Steal (Rating Upgrade)
Aug 10ResMed's (NYSE:RMD) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 07ResMed (NYSE:RMD) Has Some Way To Go To Become A Multi-Bagger
Jul 30Here's Why We Think ResMed (NYSE:RMD) Might Deserve Your Attention Today
Jul 16Compound Your Wealth With ResMed
Jul 04A Look At The Fair Value Of ResMed Inc. (NYSE:RMD)
Jul 02We Think ResMed (NYSE:RMD) Can Stay On Top Of Its Debt
May 26Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($2.6B) de RMD superan a sus pasivos a corto plazo ($904.1M).
Pasivo a largo plazo: Los activos a corto plazo de RMD ($2.6B) superan a sus pasivos a largo plazo ($1.1B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: El ratio deuda neta-patrimonio (4.5%) de RMD se considera satisfactorio.
Reducción de la deuda: El ratio deuda-patrimonio de RMD ha pasado de 57.6% a 13% en los últimos 5 años.
Cobertura de la deuda: La deuda de RMD está bien cubierta por el flujo de caja operativo (212.6%).
Cobertura de intereses: Los pagos de intereses de la deuda de RMD están bien cubiertos por el BAIT (41x cobertura).